343
Participants
Start Date
October 31, 2004
Primary Completion Date
August 31, 2007
Study Completion Date
August 31, 2007
Licarbazepine
Placebo
Investigational Site, Staten Island
Investigational Site, Madison
Investigational Site, Farmington Hills
Investigational Site, West Allis
Investigational Site, Kansas City
Investigational Site, Shreveport
Investigational Site, Dallas
Investigational Site, Bellaire
Investigational Site, La Palma
Investigational Site, Bellevue
Investigational Site, Kirkland
Investigational Site, Somerville
Novartis Investigational Site, Vienna
Novartis investigator site, Greater Sudbury
Novartis Investigational Site, Kelowna
Novartis investigator site, London
Novartis investigator site, Montreal
Novartis investigator site, Vancouver
Novartis investigator site, Verdun
Guatemala, Bogotá
Guatemala, Medellín
Guatemala, Pareira
Novartis Investigational Site, Brno
Novartis Investigational Site, Hradec Králové
Novartis Investigational Site, Prague
Novartis Investigational Site, Berlin
Novartis Investigational Site, Bochum
Novartis Investigational Site, Dresden
Novartis Investigational Site, Ingolstadt
Novartis Investigational Site, Mannheim
Novartis Investigational Site, Würzburg
Novartis Investigational Site, Guatemala City
Novartis Investigational Site, Lima
Novartis Investigational Site, Moscow
Novartis Investigational Site, Yaroslavl
Novartis Investigational Site, Bojnice
Novartis Investigational Site, Michalovce
Novartis Investigational Site, Durban
Novartis Investigational Site, Dnipro
Novartis Investigational Site, Kiev
Novartis Investigational Site, Luhansk
Novartis Investigational Site, Odesa
Novartis Investigational Site, Simferopol
Novartis Investigational Site, Caracas
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY